Previous 10 | Next 10 |
2024-05-02 10:58:09 ET IQVIA Holdings Inc. (IQV) Q1 2024 Earnings Conference Call May 02, 2024 09:00 AM ET Company Participants Kerri Joseph - Senior Vice President, Investor Relations and Treasury Ari Bousbib - Chairman and Chief Executive Officer Ron Bruehlman ...
2024-05-02 07:05:23 ET More on IQVIA IQVIA Holdings: Strong Q4 Results Suggest A Bullish 2024 IQVIA Holdings, Inc. (IQV) Q4 2023 Earnings Call Transcript IQVIA Q1 2024 Earnings Preview IQVIA and Salesforce expand partnership to accelerate life sciences cloud ...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
Revenue of $3,737 million GAAP Net Income of $288 million, Adjusted EBITDA of $862 million GAAP Diluted Earnings per Share of $1.56, Adjusted Diluted Earnings per Share of $2.54 R&D Solutions quarterly bookings of $2.6 billion, representing a book-to-bill ratio of 1.23...
2024-05-01 11:30:26 ET More on IQVIA IQVIA Holdings: Strong Q4 Results Suggest A Bullish 2024 IQVIA Holdings, Inc. (IQV) Q4 2023 Earnings Call Transcript IQVIA and Salesforce expand partnership to accelerate life sciences cloud development Read the full art...
2024-04-23 12:57:53 ET More on Medpace Medpace Holdings, Inc. 2024 Q1 - Results - Earnings Call Presentation Medpace: Exceptional Performance, Almost Fully Priced In Medpace Holdings, Inc. (MEDP) Q4 2023 Earnings Call Transcript Medpace GAAP EPS of $3.20 beat...
IQVIA (NYSE:IQV) today announced that Wendy Stewart, president of Clinical Operations at IQVIA, and Susan Barnes, senior director of IQVIA Biotech Strategic Operations, have been honored with the Healthcare Businesswoman's Association Luminary and Rising Star Awards, respectively. Wendy earne...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release a...
2024-04-13 10:52:04 ET More on AbbVie, Amgen, etc. AbbVie: Bulletproof Fundamentals AbbVie: Despite The Run, Shares Still Look Attractive, Yielding 3.67% UnitedHealth Q1 2024 Earnings Preview: Headwinds Not Enough To Derail This Juggernaut GLP-1s benefit Park...
2024-04-10 13:49:47 ET More on Technology Select Sector SPDR ETF: XLK: It's Tech's Time To Shine Again XLK May Still Have Fuel For Growth XLK: Ring The Cash Register, It's Starting To Get Overvalued Global Stock leaders for 2030 in Fin Tech - UBS Glob...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $3,814 million GAAP Net Income of $363 million, Adjusted EBITDA of $887 million GAAP Diluted Earnings per Share of $1.97, Adjusted Diluted Earnings per Share of $2.64 R&D Solutions quarterly bookings of $2.7 billion, representing a book-to-bill ratio of 1.27...
IQVIA ™ (NYSE:IQV) today announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment 2024 survey, which measures both market impact and delivery effectiven...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2024 financial results before the market opens on Monday, July 22, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release ...